Literature DB >> 3792448

Participation of intracellular sites in the action of Ca2+ channel blockers.

E J White, H F Bradford.   

Abstract

The action of phenylalkylamine Ca2+ channel blockers D890 and D888 on Ca2+ uptake and neurotransmitter amino acid release were studied. D890, the quaternary derivative of D600, did not inhibit veratrine-induced 45Ca2+ uptake or the release of neurotransmitter amino acids from rat cerebrocortical synaptosomes, except at high concentrations (200 microM) when it was probably acting extracellularly in a non-specific manner. This contrasted with the more potent (10-50 microM) inhibitory actions of D600 and D888, and may be due to the inability of D890 to cross the synaptic plasma membrane. (-)D888 was shown to cross cell membranes and accumulate in the intracellular compartment of cerebrocortical slices and synaptosomes, where it was associated predominantly with the soluble cytoplasmic fraction.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3792448     DOI: 10.1016/0014-2999(86)90274-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Extra- and intracellular action of quaternary devapamil on muscle L-type Ca(2+)-channels.

Authors:  S Berjukov; S Aczel; B Beyer; S D Kimball; M Dichtl; S Hering; J Striessnig
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  Veratridine-induced intoxication in the isolated left atrium of the rat: effects of some anti-ischemic compounds.

Authors:  D Wermelskirchen; B Wilffert; U Nebel; A Wirth; T Peters
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-07       Impact factor: 3.000

3.  Molecular mechanism of use-dependent calcium channel block by phenylalkylamines: role of inactivation.

Authors:  S Hering; S Aczél; R L Kraus; S Berjukow; J Striessnig; E N Timin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

4.  Differential inhibition of neuronal calcium entry and [3H]-D-aspartate release by the quaternary derivatives of verapamil and emopamil.

Authors:  R A Keith; T J Mangano; P A DeFeo; G E Ernst; E J Warawa
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.